Product Name | NebuSelect™ Recombinant Human CD229/SLAMF3, mFc-tag |
---|---|
Catalog Number | NBL-241192 |
Alias/Synonyms | CD229/SLAMF3 |
Appearance | see COA |
Molecule Weight | Lys364-Asp452 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q9HBG7-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-241192-100ug | 100ug | Inquire | Inquire | |
NBL-241192-1mg | 1mg | Inquire | Inquire | |
NBL-241192-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD229/SLAMF3, mFc-tag
Catalog#:
NBL-241192
Description:
NebuSelect™ Recombinant Human CD229/SLAMF3, mFc-tag(Cat#NBL-241192) is expressed in HEK293 with mFc (IgG1) tag at the C-terminus.It contains Lys364-Asp452.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 35.56 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
CD229/SLAMF3
Target Information:
CD229 was strongly and homogeneously overexpressed on the PC of patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma, MM, and PC leukemia. CD229 was particularly overexpressed on those PC showing an abnormal phenotype such as expression of CD56. Most importantly, CD229 was also highly expressed on those cells in the patients' BM displaying the phenotype of chemotherapy-resistant and myeloma-propagating cells.
Amino Acid Sequence:
Lys364-Asp452
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.